Cargando…

Spontaneous Tumor Lysis Syndrome Secondary to Metastatic Small Cell Lung Cancer

Tumor lysis syndrome (TLS) is an oncology emergency caused by the lysis of tumor cells that releases cell contents into the blood. TLS is typically associated with leukemia following the initiation of chemotherapy. Spontaneous TLS has been seen in hematologic malignancies, but the incidence of spont...

Descripción completa

Detalles Bibliográficos
Autores principales: Koura, Simran, Parekh, Varun, Parikh, Amish D, Kaur, Kiranveer, Dunn, Bryan K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985463/
https://www.ncbi.nlm.nih.gov/pubmed/36879689
http://dx.doi.org/10.7759/cureus.34557
_version_ 1784900961367490560
author Koura, Simran
Parekh, Varun
Parikh, Amish D
Kaur, Kiranveer
Dunn, Bryan K
author_facet Koura, Simran
Parekh, Varun
Parikh, Amish D
Kaur, Kiranveer
Dunn, Bryan K
author_sort Koura, Simran
collection PubMed
description Tumor lysis syndrome (TLS) is an oncology emergency caused by the lysis of tumor cells that releases cell contents into the blood. TLS is typically associated with leukemia following the initiation of chemotherapy. Spontaneous TLS has been seen in hematologic malignancies, but the incidence of spontaneous TLS in solid tumors is rare, and only nine cases have been reported in small cell lung carcinoma. We present a case of a patient who presented with severe metabolic acidosis and electrolyte abnormalities consistent with TLS. At presentation, our patient was found to have small cell lung carcinoma with metastasis to the liver. This patient was managed with bicarbonate, rasburicase, allopurinol, and calcium replacement and started on continuous renal replacement therapy, but unfortunately was transitioned to comfort care and passed away. Risk factors for spontaneous TLS include bulky disease, elevated lactate dehydrogenase, elevated white blood cell counts, renal compromise, and abdominal organ involvement. The most common laboratory findings for TLS include metabolic acidosis and hyperuricemia, hyperphosphatemia, hyperkalemia, and hypocalcemia. Cases of spontaneous TLS, however, have been noted to have smaller elevations in phosphate levels. Spontaneous TLS is a rare but potentially fatal complication that can be seen in small cell lung carcinoma.
format Online
Article
Text
id pubmed-9985463
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-99854632023-03-05 Spontaneous Tumor Lysis Syndrome Secondary to Metastatic Small Cell Lung Cancer Koura, Simran Parekh, Varun Parikh, Amish D Kaur, Kiranveer Dunn, Bryan K Cureus Internal Medicine Tumor lysis syndrome (TLS) is an oncology emergency caused by the lysis of tumor cells that releases cell contents into the blood. TLS is typically associated with leukemia following the initiation of chemotherapy. Spontaneous TLS has been seen in hematologic malignancies, but the incidence of spontaneous TLS in solid tumors is rare, and only nine cases have been reported in small cell lung carcinoma. We present a case of a patient who presented with severe metabolic acidosis and electrolyte abnormalities consistent with TLS. At presentation, our patient was found to have small cell lung carcinoma with metastasis to the liver. This patient was managed with bicarbonate, rasburicase, allopurinol, and calcium replacement and started on continuous renal replacement therapy, but unfortunately was transitioned to comfort care and passed away. Risk factors for spontaneous TLS include bulky disease, elevated lactate dehydrogenase, elevated white blood cell counts, renal compromise, and abdominal organ involvement. The most common laboratory findings for TLS include metabolic acidosis and hyperuricemia, hyperphosphatemia, hyperkalemia, and hypocalcemia. Cases of spontaneous TLS, however, have been noted to have smaller elevations in phosphate levels. Spontaneous TLS is a rare but potentially fatal complication that can be seen in small cell lung carcinoma. Cureus 2023-02-02 /pmc/articles/PMC9985463/ /pubmed/36879689 http://dx.doi.org/10.7759/cureus.34557 Text en Copyright © 2023, Koura et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Koura, Simran
Parekh, Varun
Parikh, Amish D
Kaur, Kiranveer
Dunn, Bryan K
Spontaneous Tumor Lysis Syndrome Secondary to Metastatic Small Cell Lung Cancer
title Spontaneous Tumor Lysis Syndrome Secondary to Metastatic Small Cell Lung Cancer
title_full Spontaneous Tumor Lysis Syndrome Secondary to Metastatic Small Cell Lung Cancer
title_fullStr Spontaneous Tumor Lysis Syndrome Secondary to Metastatic Small Cell Lung Cancer
title_full_unstemmed Spontaneous Tumor Lysis Syndrome Secondary to Metastatic Small Cell Lung Cancer
title_short Spontaneous Tumor Lysis Syndrome Secondary to Metastatic Small Cell Lung Cancer
title_sort spontaneous tumor lysis syndrome secondary to metastatic small cell lung cancer
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985463/
https://www.ncbi.nlm.nih.gov/pubmed/36879689
http://dx.doi.org/10.7759/cureus.34557
work_keys_str_mv AT kourasimran spontaneoustumorlysissyndromesecondarytometastaticsmallcelllungcancer
AT parekhvarun spontaneoustumorlysissyndromesecondarytometastaticsmallcelllungcancer
AT parikhamishd spontaneoustumorlysissyndromesecondarytometastaticsmallcelllungcancer
AT kaurkiranveer spontaneoustumorlysissyndromesecondarytometastaticsmallcelllungcancer
AT dunnbryank spontaneoustumorlysissyndromesecondarytometastaticsmallcelllungcancer